Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 697,426
  • Shares Outstanding, K 449,952
  • Annual Sales, $ 52,900 K
  • Annual Income, $ -428,330 K
  • 60-Month Beta 2.31
  • Price/Sales 13.35
  • Price/Cash Flow N/A
  • Price/Book 4.50
Trade SRNE with:

Options Overview Details

View History
  • Implied Volatility 149.21% ( +29.20%)
  • Historical Volatility 90.52%
  • IV Percentile 96%
  • IV Rank 23.58%
  • IV High 400.53% on 05/24/22
  • IV Low 71.64% on 10/08/21
  • Put/Call Vol Ratio 0.85
  • Today's Volume 758
  • Volume Avg (30-Day) 4,949
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 213,148
  • Open Int (30-Day) 229,867

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.20
  • Number of Estimates 2
  • High Estimate -0.16
  • Low Estimate -0.25
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5000 +6.33%
on 10/03/22
2.4300 -34.36%
on 09/09/22
-0.4150 (-20.65%)
since 09/02/22
3-Month
1.5000 +6.33%
on 10/03/22
3.0900 -48.38%
on 07/20/22
-0.5550 (-25.81%)
since 07/01/22
52-Week
1.1500 +38.70%
on 05/12/22
7.4000 -78.45%
on 11/03/21
-4.7550 (-74.88%)
since 10/04/21

Most Recent Stories

More News
Morphic Holding, Inc. (MORF) Moves 7.3% Higher: Will This Strength Last?

Morphic Holding, Inc. (MORF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...

MORF : 28.58 (+1.56%)
SRNE : 1.5800 (+1.94%)
3 Biotech Stocks Gaining Momentum

The headlines have been particularly good for a trio of small cap biotechs and it appears the momentum may have staying power.

AMRN : 1.1700 (+4.46%)
SRNE : 1.5800 (+1.94%)
EDIT : 12.69 (+2.92%)
Sorrento (SRNE) Gets FDA Fast Track Tag for Back Pain Product

Sorrento Therapeutics' (SRNE) subsidiary Scilex receives Fast Track designation for its lower back pain (LBP) candidate, SP-103. Stock Up.

VBLT : 0.1750 (+9.37%)
SRNE : 1.5800 (+1.94%)
STRO : 5.82 (+0.52%)
IMCR : 46.23 (-0.02%)
Why Sorrento Therapeutics Stock Is Marching Higher Today

An FDA fast track designation for a high-value product candidate is powering the biotech's shares higher today.

SRNE : 1.5800 (+1.94%)
Sorrento (SRNE) Up on Positive Result From Lung Cancer Study

Sorrento Therapeutics' (SRNE) stock rises after it announced positive results from its late-stage lung cancer study evaluating abivertinib.

AZN : 56.84 (+2.32%)
SRNE : 1.5800 (+1.94%)
PLRX : 21.73 (+3.38%)
INZY : 2.60 (unch)
2 Penny Stocks That Could Make You Filthy Rich

These two penny stocks could generate life-changing gains for early shareholders.

SRNE : 1.5800 (+1.94%)
SNDL : 2.27 (+2.71%)
Why Sorrento Therapeutics Stock Is Popping Today

A positive clinical readout in lung cancer is fueling the biotech's rally today.

SRNE : 1.5800 (+1.94%)
Aridis Pharmaceuticals (ARDS) Reports Q2 Loss, Misses Revenue Estimates

Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of -650% and 97.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ARDS : 1.0900 (-1.80%)
SRNE : 1.5800 (+1.94%)
Albireo Pharma (ALBO) Reports Q2 Loss, Misses Revenue Estimates

Albireo Pharma (ALBO) delivered earnings and revenue surprises of -29.11% and 12.89%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ALBO : 19.20 (+2.40%)
SRNE : 1.5800 (+1.94%)
Urogen Pharma (URGN) Reports Q2 Loss, Lags Revenue Estimates

Urogen Pharma (URGN) delivered earnings and revenue surprises of 11.28% and 2.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

URGN : 8.58 (+3.87%)
SRNE : 1.5800 (+1.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and...

See More

Key Turning Points

3rd Resistance Point 1.7833
2nd Resistance Point 1.7167
1st Resistance Point 1.6333
Last Price 1.5800
1st Support Level 1.4833
2nd Support Level 1.4167
3rd Support Level 1.3333

See More

52-Week High 7.4000
Fibonacci 61.8% 5.0125
Fibonacci 50% 4.2750
Fibonacci 38.2% 3.5375
Last Price 1.5800
52-Week Low 1.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar